Connection

Kent Armeson to Sulfonamides

Back to Details
This is a "connection" page, showing publications Kent Armeson has written about Sulfonamides.
Kent Armeson
Connection Strength
0.178
Sulfonamides
  1. A randomized, open-label, phase 2, multicenter trial of gemcitabine with pazopanib or gemcitabine with docetaxel in patients with advanced soft-tissue sarcoma. Cancer. 2021 03 15; 127(6):894-904.
    View in: PubMed
    Score: 0.178
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.